-
2024-515310-40-01
4
2021-08-04
Patients with a confirmed diagnosis of ovarian small cell carcinoma.
-
2024-515344-23-00
4
2021-06-17
local advenced pancreatic adenocarcinoma
-
2024-517215-67-00
5
2021-06-11
Newly diagnosed Non-Frail transplant Ineligible Multiple Myeloma elder
-
2024-513427-17-00
6
2021-05-20
Well controlled severe allergic asthma
-
2023-505923-30-00
4
2021-05-11
Patients with hormone-receptor positive (HR+) and human epidermal grow
-
2022-502519-13-00
5
2021-05-07
Moderate to Severe Plaque Psoriasis
-
2023-505483-11-00
6
2021-05-02
Brain abscess
-
2023-509492-16-00
4
2021-03-30
Adult participants with metastatic (advanced) solid tumors.
-
2024-514025-30-00
4
2021-03-25
Ocular conservative treatment for retinoblastoma
-
2024-512671-12-00
10
2021-03-05
Unresectable head and neck squamous cell carcinoma, metastatic head an
-
2024-511868-83-00
5
2021-02-05
Antisynthetase syndrome-related interstitial lung disease
-
2024-516461-36-00
5
2021-01-27
Pregnancy associated hypertension, Pre-Eclampsia, Fetal growth restric
-
2022-502642-27-00
9
2020-11-26
RElapse in previously irradiated Prostate bed
-
2024-510783-23-00
7
2020-10-29
Fallopian Tube Cancer
-
2024-515384-62-00
5
2020-10-09
Soft Tissue Sarcoma
-
2024-510579-40-00
9
2020-10-07
Rhabdoyosarcoma
-
2023-508432-53-00
4
2020-09-22
Systemic sclerosis
-
2022-501050-11-01
10
2020-07-13
Acute Lymphoblastic Leukaemia
-
2024-511904-18-00
10
2020-07-08
Pancreatic adenocarcinoma (PAC)
-
2024-515276-12-00
5
2020-07-01
Postpartum Hemorrhage
-
2023-506914-32-00
4
2020-05-05
Pan tumor
-
2024-514603-34-00
5
2020-03-02
intermediate-risk differentiated thyroid cancer patients
-
2022-501454-11-00
5
2020-02-05
standard risk ALK-positive anaplastic large cell lymphoma (ALCL)
-
2024-516266-11-00
5
2020-01-06
yeast intra-abdominal infection, peritonitis